famotidine has been researched along with Colitis, Granulomatous in 4 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Histamine is a key immunoregulatory mediator in immediate-type hypersensitivity reactions and chronic inflammatory responses, in particular histamine suppresses proinflammatory responses to bacterial ligands, through histamine receptor 2 (H2R)." | 1.43 | Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease. ( Akdis, CA; Ferstl, R; Frei, R; Groeger, D; Jutel, M; Konieczna, P; OʼMahony, L; Perez, NR; Schiavi, E; Smolinska, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smolinska, S | 1 |
| Groeger, D | 1 |
| Perez, NR | 1 |
| Schiavi, E | 1 |
| Ferstl, R | 1 |
| Frei, R | 1 |
| Konieczna, P | 1 |
| Akdis, CA | 1 |
| Jutel, M | 1 |
| OʼMahony, L | 1 |
| Moriyama, T | 1 |
| Matsumoto, T | 1 |
| Jo, Y | 1 |
| Yada, S | 1 |
| Hirahashi, M | 1 |
| Yao, T | 1 |
| Iida, M | 1 |
| Miehsler, W | 1 |
| Püspök, A | 1 |
| Oberhuber, T | 1 |
| Vogelsang, H | 1 |
| Saunders, DR | 1 |
| Saunders, MD | 1 |
| Sillery, JK | 1 |
4 other studies available for famotidine and Colitis, Granulomatous
| Article | Year |
|---|---|
Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
Topics: Adult; Animals; Case-Control Studies; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Cytokines | 2016 |
Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Case-Control Studies; Chemokines; Crohn Disease; Cytokin | 2005 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |
Beneficial effects of glucose polymer and an H2-receptor blocker in a patient with a proximal ileostomy.
Topics: Adult; Carbohydrates; Combined Modality Therapy; Crohn Disease; Famotidine; Fluid Therapy; Histamine | 1989 |